Gene group | Gene targets within group | Total DEG | Number of genes tested | Enrichment (%) |
---|---|---|---|---|
Actin cytoskeleton signaling | ACTA4, ACTG1, ARHGEF6, ARHGEF7, ARPC1A, ARPC2, CDC42, F2RL1, IQGAP, LIMK2, RAC2, ROCK1, ROCK2 | 5 | 13 | 38% |
Arachidonic acid | CBR1, CBR2, CBR3, PTGES, PTGES2, PTGES3, PTGIS, PTGS1, PTGS2, TBXAS1, PLA2G4A | 6 | 11 | 55% |
Integrin signaling | FN1, GRB2, ITGA2, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, SPP1 | 10 | 13 | 77% |
Intracellular junctions | CDH1, CDH11, CDH3, CDH5, DSC1, DSC2, DSC3, DSG1, DSG2, DSG3, TJP1, TJP2, TJP3 | 8 | 13 | 62% |
Transporters | SLC1A3, SLC1A5, SLC2A1, SLC2A2, SLC2A3, SLC2A5, SLC2A10, SLC2A12, SLC7A1, SLC7A4, SLC16A1, SLC16A3, SLC16A5, SLC16A10, SLC27A4, SLC27A6 | 14 | 16 | 88% |
VEGF signaling | ARRB1, ARRB2, BCL2L14, FLT1, HIF1A, HPSE, KDR, MAPK1, MAPK3, NOS1, NOS2, NOS3, PGF, PLCG1, PLCG2, PTGR1, VEGFA, VEGFB, VEGFC, VEGFD | 11 | 20 | 55% |
House Keeping | HMBS, IPO8, MAU2, RPL32 | 4 | 0 | N/A |